EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY 4.0

Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial

Chi Fang, Suping Liu, Jie Xia, Xiaohua Wu, Guihao Ke, Jun Zhu

Journal of Cancer Research and Clinical Oncology · 2026

DOI: 10.1007/s00432-026-06555-0 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2026. Verfasst von Chi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols, Radiotherapy, Intensity-Modulated. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To prospectively explore efficacy and safety of radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer (CC).

Methods

Patients with locoregional recurrent CC were enrolled in the analysis. The enrolled patients received radiotherapy and albumin-bound paclitaxel and platinum-based chemotherapy. The primary endpoint was overall survival (OS). Secondary endpoints were progression-free survival (PFS), objective response rate (ORR), and safety.

Results

99 patients were enrolled. For all patients, the 3-year PFS and 3-year OS were 48.5% and 58.6%. 17.2% of patients achieved CR and 67.7% of patients achieved PR. The ORR was 84.8%. Moreover, 10.1% of patients were confirmed SD. The DCR was 94.9%.

Conclusion

Locoregional recurrent CC could benefit from radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, Intensity-ModulatedHumansFemaleMiddle AgedAdultAgedAlbumin-Bound PaclitaxelChemoradiotherapyProspective StudiesCisplatinPaclitaxel

Stichwörter der Autor:innen

Cervical cancerChemotherapyLocoregional recurrenceRadiotherapySurvival

Substanzen

Albumin-Bound PaclitaxelCisplatinPaclitaxel

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Digestive Endoscopic Center, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. wu.xh@fudan.edu.cn.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. wu.xh@fudan.edu.cn.
  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. kegh5734@126.com.

Zitieren

APA

Fang, C., Liu, S., Xia, J., Wu, X., Ke, G., & Zhu, J. (2026). Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06555-0

Vancouver

Fang C, Liu S, Xia J, Wu X, Ke G, Zhu J. Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial. Journal of Cancer Research and Clinical Oncology. 2026. doi:10.1007/s00432-026-06555-0

BibTeX
@article{Fang2026,
  author = {Fang, Chi and Liu, Suping and Xia, Jie and Wu, Xiaohua and Ke, Guihao and Zhu, Jun},
  title = {Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2026},
  doi = {10.1007/s00432-026-06555-0}
}
Kostenlos starten →